- Home
- EIC vs AMRN Comparison
EIC vs AMRN Comparison
Compare EIC & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EIC | AMRN |
|---|---|---|
| Founded | N/A | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.8M | 339.8M |
| IPO Year | 2019 | 1993 |
Fundamental Metrics
Financial Performance| Metric | EIC | AMRN |
|---|---|---|
| Price | $11.48 | $13.79 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $14.00 | $12.00 |
| AVG Volume (30 Days) | ★ 280.0K | 91.6K |
| Earning Date | 02-19-2026 | 10-29-2025 |
| Dividend Yield | ★ 13.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | $59,262,402.00 | ★ $226,733,000.00 |
| Revenue This Year | $37.84 | N/A |
| Revenue Next Year | $23.33 | N/A |
| P/E Ratio | $10.00 | ★ N/A |
| Revenue Growth | ★ 44.30 | N/A |
| 52 Week Low | $10.81 | $7.08 |
| 52 Week High | $16.39 | $20.90 |
Technical Indicators
Market Signals| Indicator | EIC | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 49.93 | 39.56 |
| Support Level | $11.20 | $13.48 |
| Resistance Level | $11.60 | $14.49 |
| Average True Range (ATR) | 0.22 | 0.62 |
| MACD | 0.06 | 0.05 |
| Stochastic Oscillator | 78.20 | 31.35 |
Price Performance
Historical ComparisonAbout EIC Eagle Point Income Company Inc.
Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.